- Home
- NVAX vs GAM Comparison
NVAX vs GAM Comparison
Compare NVAX & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- GAM
- Stock Information
- Founded
- NVAX 1987
- GAM 1927
- Country
- NVAX United States
- GAM United States
- Employees
- NVAX N/A
- GAM N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- GAM Investment Managers
- Sector
- NVAX Health Care
- GAM Finance
- Exchange
- NVAX Nasdaq
- GAM Nasdaq
- Market Cap
- NVAX 1.4B
- GAM 1.5B
- IPO Year
- NVAX 1995
- GAM N/A
- Fundamental
- Price
- NVAX $7.19
- GAM $63.80
- Analyst Decision
- NVAX Hold
- GAM
- Analyst Count
- NVAX 8
- GAM 0
- Target Price
- NVAX $11.38
- GAM N/A
- AVG Volume (30 Days)
- NVAX 4.2M
- GAM 20.1K
- Earning Date
- NVAX 11-06-2025
- GAM 01-01-0001
- Dividend Yield
- NVAX N/A
- GAM 5.74%
- EPS Growth
- NVAX N/A
- GAM N/A
- EPS
- NVAX 2.07
- GAM 11.67
- Revenue
- NVAX $1,064,651,000.00
- GAM N/A
- Revenue This Year
- NVAX $59.49
- GAM N/A
- Revenue Next Year
- NVAX N/A
- GAM N/A
- P/E Ratio
- NVAX $3.47
- GAM $3.95
- Revenue Growth
- NVAX 20.27
- GAM N/A
- 52 Week Low
- NVAX $5.01
- GAM $37.32
- 52 Week High
- NVAX $11.55
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- NVAX 36.23
- GAM 59.84
- Support Level
- NVAX $7.08
- GAM $62.31
- Resistance Level
- NVAX $7.90
- GAM $64.00
- Average True Range (ATR)
- NVAX 0.37
- GAM 0.82
- MACD
- NVAX -0.12
- GAM -0.04
- Stochastic Oscillator
- NVAX 7.17
- GAM 71.20
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.